SEC Form 5 · accession 0001570523-18-000017
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jun 17, 2016 | P | 2,000 | $0.185 | A | 20,800,359 | D | |
| Common stock | Jun 20, 2016 | P | 1,200 | $0.185 | A | 20,800,359 | D | |
| Common stock | Jun 20, 2016 | P | 1,000 | $0.184 | A | 20,800,359 | D | |
| Common stock | Jun 20, 2016 | P | 500 | $0.184 | A | 20,800,359 | D | |
| Common stock | Jun 24, 2016 | P | 1,000 | $0.18 | A | 20,800,359 | D | |
| Common stock | Jun 24, 2016 | P | 10,000 | $0.18 | A | 20,800,359 | D | |
| Common stock | Jun 29, 2016 | P | 500 | $0.171 | A | 20,800,359 | D | |
| Common stock | Jul 1, 2016 | P | 500 | $0.172 | A | 20,800,359 | D | |
| Common stock | Jul 1, 2016 | P | 1,000 | $0.17 | A | 20,800,359 | D | |
| Common stock | Jul 1, 2016 | P | 1,000 | $0.169 | A | 20,800,359 | D | |
| Common stock | Jul 6, 2016 | P | 1,200 | $0.1686 | A | 20,800,359 | D | |
| Common stock | Jul 6, 2016 | P | 500 | $0.1675 | A | 20,800,359 | D | |
| Common stock | Jul 6, 2016 | P | 1,000 | $0.16 | A | 20,800,359 | D | |
| Common stock | Jul 15, 2016 | P | 1,000 | $0.181 | A | 20,800,359 | D | |
| Common stock | Jul 15, 2016 | P | 2,000 | $0.182 | A | 20,800,359 | D | |
| Common stock | Jul 15, 2016 | P | 1,000 | $0.182 | A | 20,800,359 | D | |
| Common stock | Jul 20, 2016 | P | 1,000 | $0.18 | A | 20,800,359 | D | |
| Common stock | Jul 20, 2016 | P | 2,000 | $0.177 | A | 20,800,359 | D | |
| Common stock | Jul 21, 2016 | P | 1,000 | $0.172 | A | 20,800,359 | D | |
| Common stock | Jul 27, 2016 | P | 10,000 | $0.12 | A | 20,800,359 | D | |
| Common stock | Jul 28, 2016 | P | 1,000 | $0.129 | A | 20,800,359 | D | |
| Common stock | Jul 28, 2016 | P | 100 | $0.13 | A | 20,800,359 | D | |
| Common stock | Aug 2, 2016 | P | 1,000 | $0.115 | A | 20,800,359 | D | |
| Common stock | Aug 8, 2016 | P | 2,000 | $0.1275 | A | 20,800,359 | D | |
| Common stock | Aug 8, 2016 | P | 5,000 | $0.125 | A | 20,800,359 | D | |
| Common stock | Aug 10, 2016 | P | 1,000 | $0.1245 | A | 20,800,359 | D | |
| Common stock | Aug 12, 2016 | C | 3,531,738 | $0.08 | A | 20,800,359 | D | |
| Common stock | Aug 12, 2016 | C | 852,292 | $0.0123 | A | 20,800,359 | D | |
| Common stock | Aug 12, 2016 | C | 4,516,302 | $0.08 | A | 20,800,359 | D | |
| Common stock | Aug 12, 2016 | P | 6,000 | $0.119 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 13 of 16 submissions.